Does ADAGRASIB Cause Off label use? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Off label use have been filed in association with ADAGRASIB (KRAZATI). This represents 7.8% of all adverse event reports for ADAGRASIB.
70
Reports of Off label use with ADAGRASIB
7.8%
of all ADAGRASIB reports
12
Deaths
27
Hospitalizations
How Dangerous Is Off label use From ADAGRASIB?
Of the 70 reports, 12 (17.1%) resulted in death, 27 (38.6%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADAGRASIB. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does ADAGRASIB Cause?
Death (272)
Diarrhoea (113)
Hospitalisation (108)
Nausea (87)
Vomiting (79)
Asthenia (61)
Fatigue (51)
Decreased appetite (43)
Dehydration (35)
Dyspnoea (32)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ADAGRASIB Alternatives Have Lower Off label use Risk?
ADAGRASIB vs ADALIMUMAB
ADAGRASIB vs ADALIMUMAB-AACF
ADAGRASIB vs ADALIMUMAB-AATY
ADAGRASIB vs ADALIMUMAB-ADAZ
ADAGRASIB vs ADALIMUMAB-ADBM